Harvard Bioscience (HBIO) Operating Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Harvard Bioscience | 25.38 Mn | 18.29 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -477.00 |
| Dec 31, 2025 | 15,824.00 |
| Sep 30, 2025 | 20.00 |
| Jun 30, 2025 | -639.00 |
| Mar 31, 2025 | -21,434.00 |
| Dec 31, 2024 | 1,009.00 |
| Sep 30, 2024 | -355.00 |
| Jun 30, 2024 | -973.00 |
| Mar 31, 2024 | -887.00 |
| Dec 31, 2023 | -1,278.00 |
| Sep 30, 2023 | -679.00 |
| Jun 30, 2023 | 398.00 |
| Mar 31, 2023 | 1,057.00 |
| Dec 31, 2022 | 1,427.00 |
| Sep 30, 2022 | -1,189.00 |
| Jun 30, 2022 | 1,511.00 |
| Mar 31, 2022 | -2,139.00 |
| Dec 31, 2021 | 939.00 |
| Sep 30, 2021 | 510.00 |
| Jun 30, 2021 | 341.00 |
| Mar 31, 2021 | -7.00 |
| Dec 31, 2020 | 284.00 |
| Sep 30, 2020 | 377.00 |
| Jun 30, 2020 | 204.00 |
| Mar 31, 2020 | -931.00 |
| Dec 31, 2019 | -171.00 |
| Sep 30, 2019 | -1,058.00 |
| Jun 30, 2019 | -568.00 |
| Mar 31, 2019 | -558.00 |
| Dec 31, 2018 | 855.00 |
| Sep 30, 2018 | 146.00 |
| Jun 30, 2018 | -407.00 |
| Mar 31, 2018 | -981.00 |
| Dec 31, 2017 | -584.00 |
| Sep 30, 2017 | -651.00 |
| Jun 30, 2017 | -1,010.00 |
| Mar 31, 2017 | -922.00 |
| Dec 31, 2016 | -903.00 |
| Sep 30, 2016 | -409.00 |
| Jun 30, 2016 | -1,249.00 |
| Mar 31, 2016 | -823.00 |
| Dec 31, 2015 | -952.00 |
| Sep 30, 2015 | -1,036.00 |
| Jun 30, 2015 | -881.00 |